Egetis Therapeutics AB (LTS:0ABW) Other Net Income (Loss) : kr0.10 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Egetis Therapeutics AB Other Net Income (Loss)?

Egetis Therapeutics AB's Other Net Income (Loss) for the three months ended in Sep. 2024 was kr0.10 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.10 Mil.

Egetis Therapeutics AB's quarterly Other Net Income (Loss) stayed the same from Mar. 2024 (kr0.00 Mil) to Jun. 2024 (kr0.00 Mil) but then increased from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr0.10 Mil).

Egetis Therapeutics AB's annual Other Net Income (Loss) stayed the same from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Egetis Therapeutics AB Other Net Income (Loss) Historical Data

The historical data trend for Egetis Therapeutics AB's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Other Net Income (Loss) Chart

Egetis Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Egetis Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial															0.10	-	-	-	0.10

Egetis Therapeutics AB Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.10 Mil.

Egetis Therapeutics AB Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (LTS:0ABW) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

EGTX:Sweden P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines